Who Paid My Doc
Vivaer Stylus
Device Ear Nose & Throat
PDI 08886479300160
General payments
$3,333,584
Research payments
$2,786,736
Through program year 2025, $3,333,584 in general payments and $2,786,736 in research payments were reported against Vivaer Stylus (Ear Nose & Throat).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,450,120 | 7,130 |
| 2025 | Research | $977,859 | 194 |
| 2024 | General | $817,952 | 6,129 |
| 2024 | Research | $188,672 | 74 |
| 2023 | General | $485,242 | 4,345 |
| 2023 | Research | $164,099 | 72 |
| 2022 | General | $242,220 | 174 |
| 2022 | Research | $627,187 | 107 |
| 2021 | General | $338,050 | 874 |
| 2021 | Research | $828,919 | 101 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 80 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18,652 general · 548 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.